HK1200697A1 - 搔癢症治療藥 - Google Patents
搔癢症治療藥Info
- Publication number
- HK1200697A1 HK1200697A1 HK15101091.9A HK15101091A HK1200697A1 HK 1200697 A1 HK1200697 A1 HK 1200697A1 HK 15101091 A HK15101091 A HK 15101091A HK 1200697 A1 HK1200697 A1 HK 1200697A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- pruritus
- therapeutic agent
- therapeutic
- agent
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2869—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against hormone receptors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/21—Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Endocrinology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Dermatology (AREA)
- Neurology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2007315144 | 2007-12-05 |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1200697A1 true HK1200697A1 (zh) | 2015-08-14 |
Family
ID=40717776
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK11105302.9A HK1151226A1 (zh) | 2007-12-05 | 2011-05-27 | 搔癢症治療藥 |
HK15101091.9A HK1200697A1 (zh) | 2007-12-05 | 2015-02-02 | 搔癢症治療藥 |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK11105302.9A HK1151226A1 (zh) | 2007-12-05 | 2011-05-27 | 搔癢症治療藥 |
Country Status (14)
Country | Link |
---|---|
US (1) | US8431127B2 (zh) |
EP (1) | EP2241332A4 (zh) |
JP (1) | JP5475460B2 (zh) |
KR (1) | KR101595134B1 (zh) |
CN (2) | CN101939025B (zh) |
AU (1) | AU2008332276B2 (zh) |
BR (1) | BRPI0821145B8 (zh) |
CA (1) | CA2708065C (zh) |
HK (2) | HK1151226A1 (zh) |
MX (1) | MX2010006097A (zh) |
MY (2) | MY162546A (zh) |
RU (2) | RU2541780C2 (zh) |
TW (1) | TWI441649B (zh) |
WO (1) | WO2009072598A1 (zh) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP4342995A3 (en) | 2006-03-31 | 2024-05-15 | Chugai Seiyaku Kabushiki Kaisha | Methods for controlling blood pharmacokinetics of antibodies |
UA100116C2 (ru) | 2006-06-08 | 2012-11-26 | Чугей Сейяку Кабусики Кайся | Профилактика или лечение воспалительного заболевания |
DK2202245T3 (en) | 2007-09-26 | 2016-11-21 | Chugai Pharmaceutical Co Ltd | A method of modifying an antibody isoelectric point VIA amino acid substitution in CDR |
WO2009041613A1 (ja) | 2007-09-26 | 2009-04-02 | Chugai Seiyaku Kabushiki Kaisha | 抗体定常領域改変体 |
KR101840994B1 (ko) | 2007-12-05 | 2018-03-21 | 추가이 세이야쿠 가부시키가이샤 | 항nr10 항체 및 그의 이용 |
EP2241332A4 (en) | 2007-12-05 | 2011-01-26 | Chugai Pharmaceutical Co Ltd | THERAPEUTIC AGENT AGAINST PRITURE |
EP3056513A1 (en) | 2008-04-11 | 2016-08-17 | Chugai Seiyaku Kabushiki Kaisha | Antigen-binding molecule capable of binding to two or more antigen molecules repeatedly |
JP5139517B2 (ja) * | 2008-12-05 | 2013-02-06 | 中外製薬株式会社 | 抗nr10抗体、およびその利用 |
JP2010210772A (ja) * | 2009-03-13 | 2010-09-24 | Dainippon Screen Mfg Co Ltd | 液晶表示装置の製造方法 |
TWI544077B (zh) | 2009-03-19 | 2016-08-01 | Chugai Pharmaceutical Co Ltd | Antibody constant region change body |
US9228017B2 (en) | 2009-03-19 | 2016-01-05 | Chugai Seiyaku Kabushiki Kaisha | Antibody constant region variant |
BR112012027900A2 (pt) | 2010-04-30 | 2020-05-12 | Alexion Pharmaceuticals, Inc. | Anticorpos anti-c5a e métodos para usar os anticorpos |
RU2658504C9 (ru) | 2010-11-30 | 2018-08-21 | Чугаи Сейяку Кабусики Кайся | Антигенсвязывающая молекула, способная многократно связываться с множеством антигенных молекул |
US9770195B2 (en) * | 2012-08-09 | 2017-09-26 | The Regents Of The University Of California | Automated scratch detection system and signal processing algorithm for the study of pruritus in animals |
AU2016248786B2 (en) * | 2015-04-14 | 2022-01-20 | Chugai Seiyaku Kabushiki Kaisha | Pharmaceutical composition for prevention and/or treatment of atopic dermatitis containing lL-31 antagonist as active ingredient |
MA43918A (fr) | 2015-04-14 | 2018-12-05 | Chugai Pharmaceutical Co Ltd | Composition pharmaceutique pour la prã‰vention et/ou le traitement de la dermatite atopique contenant comme principe actif un antagoniste de l'il-31 |
CN107849128A (zh) | 2015-07-16 | 2018-03-27 | 伊莱利利公司 | 瘙痒治疗 |
CN110563844A (zh) * | 2019-09-04 | 2019-12-13 | 华中农业大学 | 一种抗犬白介素31受体的多克隆抗体及其应用 |
CA3156713A1 (en) | 2019-11-20 | 2021-05-27 | Daisuke Kameoka | Antibody-containing preparation |
KR102269716B1 (ko) | 2020-09-01 | 2021-06-28 | 추가이 세이야쿠 가부시키가이샤 | Il-31 안타고니스트를 유효 성분으로서 함유하는, 투석 소양증의 예방용 및/또는 치료용 의약 조성물 |
CA3211221A1 (en) * | 2021-02-22 | 2022-08-25 | Zoetis Services Llc | Horse il-31 induced pruritus model |
Family Cites Families (76)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3773919A (en) | 1969-10-23 | 1973-11-20 | Du Pont | Polylactide-drug mixtures |
IE52535B1 (en) | 1981-02-16 | 1987-12-09 | Ici Plc | Continuous release pharmaceutical compositions |
US5156840A (en) | 1982-03-09 | 1992-10-20 | Cytogen Corporation | Amine-containing porphyrin derivatives |
JPS58201994A (ja) | 1982-05-21 | 1983-11-25 | Hideaki Hagiwara | 抗原特異的ヒト免疫グロブリンの生産方法 |
HUT35524A (en) | 1983-08-02 | 1985-07-29 | Hoechst Ag | Process for preparing pharmaceutical compositions containing regulatory /regulative/ peptides providing for the retarded release of the active substance |
US5057313A (en) | 1986-02-25 | 1991-10-15 | The Center For Molecular Medicine And Immunology | Diagnostic and therapeutic antibody conjugates |
GB8607679D0 (en) | 1986-03-27 | 1986-04-30 | Winter G P | Recombinant dna product |
JP2898064B2 (ja) | 1989-08-03 | 1999-05-31 | 忠三 岸本 | ヒトgp130蛋白質 |
GB9015198D0 (en) | 1990-07-10 | 1990-08-29 | Brien Caroline J O | Binding substance |
ES2139598T3 (es) | 1990-07-10 | 2000-02-16 | Medical Res Council | Procedimientos para la produccion de miembros de parejas de union especifica. |
GB9016440D0 (en) | 1990-07-26 | 1990-09-12 | Elopak Systems | A laminate |
DK0546073T3 (da) | 1990-08-29 | 1998-02-02 | Genpharm Int | Frembringelse og anvendelse af transgene, ikke-humane dyr, der er i stand til at danne heterologe antistoffer |
AU665025B2 (en) | 1991-09-23 | 1995-12-14 | Cambridge Antibody Technology Limited | Production of chimeric antibodies - a combinatorial approach |
ES2227512T3 (es) | 1991-12-02 | 2005-04-01 | Medical Research Council | Produccion de anticuerpos contra auto-antigenos a partir de repertorios de segmentos de anticuerpos fijados en un fago. |
EP0746609A4 (en) | 1991-12-17 | 1997-12-17 | Genpharm Int | NON-HUMAN TRANSGENIC ANIMALS CAPABLE OF PRODUCING HETEROLOGOUS ANTIBODIES |
CA2131151A1 (en) | 1992-03-24 | 1994-09-30 | Kevin S. Johnson | Methods for producing members of specific binding pairs |
AU675661B2 (en) | 1992-07-24 | 1997-02-13 | Abgenix, Inc. | Generation of xenogeneic antibodies |
BR9204244A (pt) | 1992-10-26 | 1994-05-03 | Cofap | Ferro fundido cinzento |
AU689090B2 (en) | 1992-12-01 | 1998-03-26 | Protein Design Labs, Inc. | Humanized antibodies reactive with L-selectin |
EP0754225A4 (en) | 1993-04-26 | 2001-01-31 | Genpharm Int | HETEROLOGIC ANTIBODY-PRODUCING TRANSGENIC NON-HUMAN ANIMALS |
GB9313509D0 (en) | 1993-06-30 | 1993-08-11 | Medical Res Council | Chemisynthetic libraries |
EP0731842A1 (en) | 1993-12-03 | 1996-09-18 | Medical Research Council | Recombinant binding proteins and peptides |
US5783672A (en) | 1994-05-26 | 1998-07-21 | Immunex Corporation | Receptor for oncostatin M |
US5994524A (en) | 1994-07-13 | 1999-11-30 | Chugai Seiyaku Kabushiki Kaisha | Polynucleotides which encode reshaped IL-8-specific antibodies and methods to produce the same |
US5876950A (en) | 1995-01-26 | 1999-03-02 | Bristol-Myers Squibb Company | Monoclonal antibodies specific for different epitopes of human GP39 and methods for their use in diagnosis and therapy |
FR2729855A1 (fr) * | 1995-01-26 | 1996-08-02 | Oreal | Utilisation d'un antagoniste de cgrp dans une composition cosmetique, pharmaceutique ou dermatologique et composition obtenue |
EP0822830B1 (en) | 1995-04-27 | 2008-04-02 | Amgen Fremont Inc. | Human anti-IL-8 antibodies, derived from immunized xenomice |
EP0823941A4 (en) | 1995-04-28 | 2001-09-19 | Abgenix Inc | HUMAN ANTIBODIES DERIVED FROM IMMUNIZED XENO MOUSES |
AUPN481295A0 (en) | 1995-08-16 | 1995-09-07 | Medvet Science Pty. Ltd. | Agonists of haemopoietic growth factors |
ES2233974T3 (es) * | 1995-09-11 | 2005-06-16 | Kyowa Hakko Kogyo Co., Ltd. | Anticuerpo contra la cadena alfa del receptor de la interleucina 5 humana. |
AUPN564195A0 (en) | 1995-09-26 | 1995-10-19 | Walter And Eliza Hall Institute Of Medical Research, The | A novel haemopoietin receptor and genetic sequences encoding same |
WO1997015663A1 (en) | 1995-10-23 | 1997-05-01 | Amrad Operations Pty. Ltd. | A novel haemopoietin receptor and genetic sequences encoding same |
US6642360B2 (en) * | 1997-12-03 | 2003-11-04 | Genentech, Inc. | Secreted polypeptides that stimulate release of proteoglycans from cartilage |
FR2761994B1 (fr) | 1997-04-11 | 1999-06-18 | Centre Nat Rech Scient | Preparation de recepteurs membranaires a partir de baculovirus extracellulaires |
US6747137B1 (en) * | 1998-02-13 | 2004-06-08 | Genome Therapeutics Corporation | Nucleic acid sequences relating to Candida albicans for diagnostics and therapeutics |
AU759689B2 (en) | 1998-06-24 | 2003-04-17 | Chugai Seiyaku Kabushiki Kaisha | Novel hemopoietin receptor proteins |
JP2002534959A (ja) | 1998-12-08 | 2002-10-22 | バイオベーション リミテッド | 免疫原性タンパク質の改変方法 |
US20030082734A1 (en) * | 1999-06-01 | 2003-05-01 | Dowling Lynette M. | Mammalian receptor proteins; related reagents and methods |
AU5305300A (en) | 1999-06-01 | 2000-12-18 | Schering Corporation | Mammalian receptor proteins; related reagents and methods |
AU4952400A (en) * | 1999-06-02 | 2000-12-28 | Chugai Research Institute For Molecular Medicine, Inc. | Novel hemopoietin receptor protein nr10 |
EP1221482B1 (en) * | 1999-09-27 | 2005-12-28 | Chugai Seiyaku Kabushiki Kaisha | Hemopoietin receptor protein, nr12 |
NZ522146A (en) * | 2000-05-10 | 2004-10-29 | Schering Corp | Mammalian receptor-like proteins, designated DNAX cytokine receptor subunits (DCRS), in particular DCRS5 |
CA2412239C (en) | 2000-06-26 | 2013-05-28 | Zymogenetics, Inc. | Cytokine receptor zcytor17 |
US20030096339A1 (en) * | 2000-06-26 | 2003-05-22 | Sprecher Cindy A. | Cytokine receptor zcytor17 |
AU2318202A (en) | 2000-10-06 | 2002-04-15 | Immunex Corp | Hematopoietin receptors hpr1 and hpr2 |
WO2002077230A1 (fr) | 2001-03-26 | 2002-10-03 | Chugai Seiyaku Kabushiki Kaisha | Variants d'epissage nr10 |
EP1576112B1 (en) * | 2002-01-18 | 2012-02-29 | ZymoGenetics, Inc. | Cytokine receptor zcytor17 multimers |
US7064186B2 (en) * | 2002-01-18 | 2006-06-20 | Zymogenetics, Inc. | Cytokine zcytor17 ligand |
CA2477249A1 (en) | 2002-02-25 | 2003-09-04 | Genentech, Inc. | Novel type-1 cytokine receptor glm-r |
US7579000B2 (en) * | 2002-05-01 | 2009-08-25 | Bayer Schering Pharma Ag | Tissue factor targeted antibodies as anticoagulants |
BR0304659A (pt) | 2002-05-01 | 2004-09-21 | Schering Ag | Fator de tecido de proteìnas de fusão alvos trombomodulina como anticoagulantes |
AU2003242024A1 (en) | 2002-06-05 | 2003-12-22 | Chugai Seiyaku Kabushiki Kaisha | Method of constructing antibody |
US20040223970A1 (en) * | 2003-02-28 | 2004-11-11 | Daniel Afar | Antibodies against SLC15A2 and uses thereof |
EP1605974B1 (en) | 2003-03-04 | 2014-11-12 | Alexion Pharmaceuticals, Inc. | Method of treating autoimmune disease by inducing antigen presentation by tolerance inducing antigen presenting cells |
EA009124B1 (ru) | 2003-03-24 | 2007-10-26 | Займоджинетикс, Инк. | Антитела против il-20 и связывающие партнеры, а также способы их применения при воспалении |
ATE490787T1 (de) | 2003-07-15 | 2010-12-15 | Chugai Pharmaceutical Co Ltd | Produktion von igm durch transformierte zellen und verfahren zur quantifizierung dieser igm- produktion |
US20060019342A1 (en) | 2004-06-25 | 2006-01-26 | Medimmune, Inc. | Increasing the production of recombinant antibodies in mammalian cells by site-directed mutagenesis |
EP1671642A1 (en) | 2004-12-15 | 2006-06-21 | Universite D'angers | Compositions comprising (ant)agonists of oncostatin M (OSM), IL-31 and IFN-gamma for modulating keratinocyte migration and functions via a receptor containing OSMRbeta as a subunit, and applications thereof. |
NO346624B1 (no) | 2004-12-28 | 2022-11-07 | Univ Di Genova | Monoklonale antistoff mot NKG2A |
JP2008528039A (ja) | 2005-01-28 | 2008-07-31 | ザイモジェネティクス,インコーポレイティド | Il−31の均質調製物 |
WO2006088855A1 (en) * | 2005-02-14 | 2006-08-24 | Zymogenetics, Inc. | Methods of treating skin disorders using an il-31ra antagonist |
MX2007009471A (es) * | 2005-02-14 | 2008-02-15 | Zymogenetics Inc | Metodos de tratamiento de enfermedades que son mediadas por las celulas positivas al antigeno del linfocito cutaneo. |
PE20061323A1 (es) | 2005-04-29 | 2007-02-09 | Rinat Neuroscience Corp | Anticuerpos dirigidos contra el peptido amiloide beta y metodos que utilizan los mismos |
US8003108B2 (en) | 2005-05-03 | 2011-08-23 | Amgen Inc. | Sclerostin epitopes |
BRPI0611069A2 (pt) | 2005-05-06 | 2010-11-09 | Zymogenetics Inc | anticorpo monoclonal, anticorpo humanizado, fragmento de anticorpo, uso de um antagonista, e, hibridoma |
JP2009526756A (ja) | 2006-01-10 | 2009-07-23 | ザイモジェネティクス, インコーポレイテッド | Il−31raアンタゴニストおよびosmrbアンタゴニストを用いて神経組織における疼痛および炎症を治療する方法 |
UA100116C2 (ru) | 2006-06-08 | 2012-11-26 | Чугей Сейяку Кабусики Кайся | Профилактика или лечение воспалительного заболевания |
EP2032602B1 (en) * | 2006-06-15 | 2013-03-27 | The Board of Trustees of the University of Arkansas | Monoclonal antibodies that selectively recognize methamphetamine and methamphetamine like compounds |
EP2069404B1 (en) * | 2007-02-14 | 2011-01-05 | Vaccinex, Inc. | Humanized anti-cd100 antibodies |
TR201821029T4 (tr) | 2007-02-23 | 2019-01-21 | Merck Sharp & Dohme | Geliştirilmiş antı-IL-23p19 antikorları. |
GB0708002D0 (en) | 2007-04-25 | 2007-06-06 | Univ Sheffield | Antibodies |
WO2009041613A1 (ja) | 2007-09-26 | 2009-04-02 | Chugai Seiyaku Kabushiki Kaisha | 抗体定常領域改変体 |
DK2202245T3 (en) | 2007-09-26 | 2016-11-21 | Chugai Pharmaceutical Co Ltd | A method of modifying an antibody isoelectric point VIA amino acid substitution in CDR |
WO2009041621A1 (ja) | 2007-09-26 | 2009-04-02 | Chugai Seiyaku Kabushiki Kaisha | 抗il-6レセプター抗体 |
EP2241332A4 (en) | 2007-12-05 | 2011-01-26 | Chugai Pharmaceutical Co Ltd | THERAPEUTIC AGENT AGAINST PRITURE |
KR101840994B1 (ko) * | 2007-12-05 | 2018-03-21 | 추가이 세이야쿠 가부시키가이샤 | 항nr10 항체 및 그의 이용 |
-
2008
- 2008-12-05 EP EP08857461A patent/EP2241332A4/en not_active Withdrawn
- 2008-12-05 TW TW097147375A patent/TWI441649B/zh active
- 2008-12-05 MX MX2010006097A patent/MX2010006097A/es active IP Right Grant
- 2008-12-05 RU RU2010127291/10A patent/RU2541780C2/ru active
- 2008-12-05 CN CN200880126534.1A patent/CN101939025B/zh active Active
- 2008-12-05 US US12/746,229 patent/US8431127B2/en active Active
- 2008-12-05 WO PCT/JP2008/072142 patent/WO2009072598A1/ja active Application Filing
- 2008-12-05 KR KR1020107014699A patent/KR101595134B1/ko active IP Right Grant
- 2008-12-05 MY MYPI2010002563A patent/MY162546A/en unknown
- 2008-12-05 BR BRPI0821145A patent/BRPI0821145B8/pt active IP Right Grant
- 2008-12-05 AU AU2008332276A patent/AU2008332276B2/en active Active
- 2008-12-05 CN CN201410451948.9A patent/CN104162155A/zh active Pending
- 2008-12-05 MY MYPI2016002081A patent/MY185647A/en unknown
- 2008-12-05 RU RU2014150548/10A patent/RU2596397C2/ru active
- 2008-12-05 CA CA2708065A patent/CA2708065C/en active Active
- 2008-12-05 JP JP2009544731A patent/JP5475460B2/ja active Active
-
2011
- 2011-05-27 HK HK11105302.9A patent/HK1151226A1/zh unknown
-
2015
- 2015-02-02 HK HK15101091.9A patent/HK1200697A1/zh unknown
Also Published As
Publication number | Publication date |
---|---|
RU2541780C2 (ru) | 2015-02-20 |
CN104162155A (zh) | 2014-11-26 |
MY162546A (en) | 2017-06-15 |
BRPI0821145B8 (pt) | 2021-05-25 |
RU2014150548A (ru) | 2015-07-20 |
AU2008332276B2 (en) | 2014-02-27 |
JPWO2009072598A1 (ja) | 2011-04-28 |
CN101939025B (zh) | 2015-03-25 |
KR20100100935A (ko) | 2010-09-15 |
US20100310556A1 (en) | 2010-12-09 |
CA2708065A1 (en) | 2009-06-11 |
CA2708065C (en) | 2015-02-24 |
EP2241332A4 (en) | 2011-01-26 |
TWI441649B (zh) | 2014-06-21 |
EP2241332A1 (en) | 2010-10-20 |
KR101595134B1 (ko) | 2016-02-17 |
HK1151226A1 (zh) | 2012-01-27 |
WO2009072598A1 (ja) | 2009-06-11 |
MX2010006097A (es) | 2010-08-04 |
BRPI0821145B1 (pt) | 2019-10-15 |
MY185647A (en) | 2021-05-27 |
AU2008332276A1 (en) | 2009-06-11 |
US8431127B2 (en) | 2013-04-30 |
RU2596397C2 (ru) | 2016-09-10 |
TW200932265A (en) | 2009-08-01 |
CN101939025A (zh) | 2011-01-05 |
RU2010127291A (ru) | 2012-01-10 |
BRPI0821145A2 (pt) | 2015-06-16 |
JP5475460B2 (ja) | 2014-04-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1200697A1 (zh) | 搔癢症治療藥 | |
EP2117311A4 (en) | THERAPEUTICS | |
EP2211620A4 (en) | THERAPEUTIC COMPOUNDS | |
EP2127671A4 (en) | THERAPEUTIC AGENT AGAINST CANCER | |
HRP20130041T8 (en) | Therapeutic agents | |
EP2123253A4 (en) | AGENT FOR PREVENTING AND MODIFYING WRINKLES | |
GB0716532D0 (en) | Therapeutic compounds | |
GB0813087D0 (en) | Therapeutic compounds | |
GB0723747D0 (en) | Therapeutic agents | |
EP2236594A4 (en) | DISPOSAL AGENT OF A BIOLFILM | |
ZA201100904B (en) | Therapeutic agent for migraine | |
EP2164324A4 (en) | THERAPEUTIC COMPOUNDS | |
EP2221057A4 (en) | MEANS FOR IMPROVING THE SENSES | |
EP2185568A4 (en) | THERAPEUTIC COMPOUNDS | |
EP2168955A4 (en) | SLEEP IMPROVEMENT AGENT | |
EP2140876A4 (en) | THERAPEUTIC AGENT COMPRISING VASOHIBINE | |
EP2172195A4 (en) | MEANS OF CHOLESTEROL CONTROL | |
GB0701321D0 (en) | Agent | |
GB0723748D0 (en) | Therapeutic agents | |
GB0702862D0 (en) | Therapeutic compounds | |
ZA201003835B (en) | Therapeutic agent for ulcer | |
EP2324827A4 (en) | THERAPEUTIC ACTIVE FOR ANCA-ASSOCIATED VASCULITIDES | |
GB0708188D0 (en) | Therapeutic compounds | |
EP2206510A4 (en) | THERAPEUTIC AGENT FOR DIABETES | |
GB0723751D0 (en) | Therapeutic agents |